Wealthspire Advisors (New York)’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$536K Buy
+2,748
New +$570K ﹤0.01% 778
2026
Q1
– Sell
-937
Closed -$226K – 1068
2025
Q4
$226K Buy
937
+799
+579% +$204K ﹤0.01% 920
2025
Q3
$37.8K Buy
+138
New +$37.7K ﹤0.01% 1348
2022
Q1
– Sell
-812
Closed -$212K – 533
2021
Q4
$212K Sell
812
-81
-9% -$21K ﹤0.01% 511
2021
Q3
$235K Buy
+893
New +$244K ﹤0.01% 515
2021
Q2
– Sell
-1,658
Closed -$322K – 599
2021
Q1
$322K Buy
1,658
+154
+10% +$30.9K 0.01% 529
2020
Q4
$320K Buy
+1,504
New +$300K 0.01% 420
2020
Q2
– Sell
-1,749
Closed -$258K – 471
2020
Q1
$258K Buy
+1,749
New +$279K 0.01% 424
2019
Q1
– Sell
-14
Closed -$2K – 642
2018
Q4
$2K Buy
+14
New +$1.5K ﹤0.01% 765

Other funds holding RMD

Wealthspire Advisors (New York)'s RMD Position: Q2 2026 in Review

Wealthspire Advisors (New York) opened a new position in ResMed (RMD) in Q2 2026: 2,748 shares worth $536K. The stake represents ﹤0.01% of the portfolio and ranks #778 among its holdings. This is a return to the name: Wealthspire Advisors (New York) previously reported a position in RMD as recently as Q4 2025.

Wealthspire Advisors (New York) first reported a position in RMD in Q4 2018 and has held it in 9 quarters since. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Wealthspire Advisors (New York) held 2,748 shares of ResMed worth $536K as of Q2 2026.
  • ResMed was a new Wealthspire Advisors (New York) position in Q2 2026.
  • ResMed made up ﹤0.01% of Wealthspire Advisors (New York)'s portfolio in Q2 2026, its #778 holding.
  • Wealthspire Advisors (New York) first reported a position in ResMed in Q4 2018 and has held it in 9 quarters since.
  • 891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Wealthspire Advisors (New York)'s 13F filing for Q2 2026, filed 11 Aug 2026.